Skip to main content
Log in

Prospective randomized trial comparing a nitinol self-expanding coronary stent with low-pressure dilatation and a high-pressure balloon expandable bare metal stent

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

The recent SCORES trial demonstrated that lower dilatation pressures seen with self-expanding (SE) stents may be associated with lower rates of target lesion revascularization (TLR). To determine whether SE stents with low-pressure dilatation are as safe and effective as balloon expandable (BE) stents. We randomly assigned 254 patients with 279 coronary lesions to groups receiving either SE with low-pressure dilatation <12 atm (n = 143) or conventional BE stents (n = 136). Thereafter, acute results and long-term outcomes were compared. Baseline patient and angiographic characteristics were similar in two groups. The incidence of procedural complications, such as slow flow, side branch occlusion, and edge dissection were significantly lower in the SE group than in the BE group (overall: SE, 17; BE, 35; P < 0.01), and the occurrence of myocardial infarction tended to be lower in SE than in BE (SE, 1; BE, 4; not significant). Although acute gain was significantly smaller with SE than BE (SE, 2.21 ± 0.65 mm; BE, 2.42 ± 0.62; P < 0.01), probably due to gradual expansion of the SE stent, nearly identical minimum luminal diameters on follow-up angiography (SE, 2.14 ± 0.92 mm vs. BE, 2.22 ± 0.93; not significant) and similar angiographic restenosis (SE, 18.1% vs. BE, 20.5%). and TLR rates (SE, 16.1% vs. BE, 14.0%) were apparent. This prospective randomized trial demonstrates that SE stents with low-pressure dilatation is safe and effective strategy for treating coronary arterial stenosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Han RO, Schwartz RS, Kobayashi Y, Wilson SH, Mann JT, Sketch MH, Safian RD, Lansky A, Popma J, Fitzgerald PJ, Palacios IF, Chazin-Caldie M, Goldberg S (2001) Comparison of selfexpanding and balloon-expandable stents for the reduction of restenosis Am J Cardiol 88:253–259

    Article  PubMed  CAS  Google Scholar 

  2. Kobayashi Y, Honda Y, Christie GL, Teirstein PS, Bailey SR, Brown CL 3rd, Matthews RV, De Franco AC, Schwartz RS, Goldberg S, Popma JJ, Yock PG, Fitzgerald PJ (2001) Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial. A Stent vs. Stent Ultrasound Remodeling Evaluation: J Am Coll Cardiol 37:1329–1334

    Article  PubMed  CAS  Google Scholar 

  3. Konig A, Schiele TM, Rieber J, Theisen K, Mudra H, Klauss V (2002) Stent design-related coronary artery remodeling and patterns of neointima formation following self-expanding and balloon expandable stent implantation. Catheter Cardiovasc Interv 56:486–487

    Article  Google Scholar 

  4. Hirayama A, Kodama K, Adachi T, Nanto S, Ohara T, Tamai H, Kyo E, Isshiki T, Ochiai M (2000) Angiographic and clinical outcome of a new self-expanding intracoronary stent (RADIUS): results from multicenter experience in Japan. Catheter Cardiovasc Interv 49:401–407

    Article  PubMed  CAS  Google Scholar 

  5. Bahrmann P, Werner GS, Heusch G, Ferrari M, Poerner TC, Voss A, Figulla HR (2007) Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Circulation 115:600–608

    Article  PubMed  Google Scholar 

  6. Veselka J, Prochazkova S, Duchonova R, Homolova I, Tesar D, Bybee KA (2006) Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention. Heart Vessels 21:146–151

    Article  PubMed  Google Scholar 

  7. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G; ARMYDA Investigators (2004) Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 110:674–678

    Article  PubMed  CAS  Google Scholar 

  8. Dirschinger J, Kastrati A, Neumann FJ, Boekstegers P, Elezi S, Mehilli J, Schuhlen H, Pache J, Alt E, Blasini R, Steinbeck G, Schomig A (1999) Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation. Circulation 100:918–923

    PubMed  CAS  Google Scholar 

  9. Uretsky BF, Rosanio S, Lerakis S, Wang FW, Smiley M, Stouffer GA, Tocchi M, Estella P (2000) A prospective evaluation of angiography-guided coronary stent implantation with high versus very high balloon inflation pressure. Am Heart J 140:804–812

    Article  PubMed  CAS  Google Scholar 

  10. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ (1997) Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30:1428–1436

    Article  PubMed  CAS  Google Scholar 

  11. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323

    Article  PubMed  CAS  Google Scholar 

  12. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O’shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME (2005) Comparison of a polymer-based paclitaxeleluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294:1215–1223

    Article  PubMed  CAS  Google Scholar 

  13. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schuhlen H, Schmitt C, Dirschinger J, Schomig A; ISAR-DESIRE Study Investigators (2005) Sirolimus-eluting stent or paclitaxeleluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293:165–171

    Article  PubMed  CAS  Google Scholar 

  14. Uchida T, Bakhai A, Almonacid A, Shibata T, Cox B, Kuntz RE (2006) A meta-analysis of randomized controlled trials of intracoronary gamma-and beta-radiation therapy for in-stent restenosis. Heart Vessels 21:368–374

    Article  PubMed  Google Scholar 

  15. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D, Ellis S, Holmes DR, Kerieakes D, Kuntz RE (2001) Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 344:250–256

    Article  PubMed  CAS  Google Scholar 

  16. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130

    Article  PubMed  CAS  Google Scholar 

  17. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364:1519–1521

    Article  PubMed  CAS  Google Scholar 

  18. Kereiakes DJ, Choo JK, Young JJ, Broderick TM (2004) Thrombosis and Drug-Eluting Stents: A Critical Appraisal. Rev Cardiovasc Med 5:9–15

    Article  PubMed  Google Scholar 

  19. Kandzari DE, Goldberg S, Schwartz RS, Chazin-Caldie M, Sketch MH Jr, SCORES SVG investigators (2003) Clinical and angiographical efficacy of a self expandable nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. Am Heart J 145:868–874

    Article  PubMed  Google Scholar 

  20. Shah VM, Mintz GS, Apple S, Weissman NJ (2002) Background incidence of late malapposition after bare-metal stent implantation. Circulation 106:1753–1755

    Article  PubMed  CAS  Google Scholar 

  21. Qureshi AI, Suri MF, New G, Wadsworth DC Jr, Dulin J, Hopkins LN (2002) Multicenter study of the feasibility and safety of using the memotherm carotid arterial stent for extracranial carotid artery stenosis. J Neurosurg 96:830–836

    Article  PubMed  Google Scholar 

  22. Mukherjee D, Kalahasti V, Roffi M, Bhatt DL, Kapadia SR, Bajzer C, Reginelli J, Ziada KM, Hughes K, Yadav JS (2001) Self-expanding stents for carotid interventions: comparison of nitinol versus stainless-steel stents. J Invasive Cardiol 13:732–735

    PubMed  CAS  Google Scholar 

  23. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–888

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinya Minatoguchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, S., Watanabe, S., Matsuo, H. et al. Prospective randomized trial comparing a nitinol self-expanding coronary stent with low-pressure dilatation and a high-pressure balloon expandable bare metal stent. Heart Vessels 23, 1–8 (2008). https://doi.org/10.1007/s00380-007-1000-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-007-1000-2

Key words

Navigation